专访Catherine Otto—从BMJ子刊Heart主编的角度看文章发表

2018-12-21 MedSci MedSci原创

Heart接受发表的文章在全球总投稿中只占12%,如何使你的文章脱颖而出?听主编Catherine Otto为你支招。图:梅斯小编与Catherine Otto教授关于Catherine M. Otto教授Catherine M. Otto,是BMJ子刊Heart的主编,同时也是华盛顿大学医学中心心血管疾病部的心血管疾病训练项目的主任。作为一位超声心动图专家,她撰写了《Practice of

Heart接受发表的文章在全球总投稿中只占12%,如何使你的文章脱颖而出?听主编Catherine Otto为你支招。


图:梅斯小编与Catherine Otto教授

关于Catherine M. Otto教授

Catherine M. Otto,是BMJ子刊Heart的主编,同时也是华盛顿大学医学中心血管疾病部的血管疾病训练项目的主任。

作为一位超声心动图专家,她撰写了《Practice of Clinical Echocardiography》、《Textbook of Clinical Echocardiography》等教科书级作品。

她主要的工作领域是瓣膜性心脏病、成人先天性心脏病和超声心动图。

Heart是英国心血管学会的官方杂志,它由BMJ集团出版。

作为一个领先的国际临床杂志,Heart旨在让心脏病学家及时了解临床心血管疾病的重要进展。因此,尽管它有一系列不同的主题,它的宗旨是发表与心血管疾病直接相关的临床实践。

Heart编辑团队由世界各国的学者组成,他们致力于吸引全世界的读者并为其提供高质量的前沿研究。

不过,Heart接受发表的文章在全球总投稿中并不算高,大约只占12%。

那么,如何使你的文章脱颖而出呢?

“好的问题”是成功的一半

Catherine Otto强调,首先, 最重要的是“问一个好问题(ask a good question)”。这个问题必须是人们想知道答案的临床相关问题,它需要基于假设来构建,并运用研究来得到答案。那么所提出的问题有趣、需要被回答且类型符合Heart杂志的读者,应该成为构思文章的第一步。

其次,对于研究者来说,需要从最开始就做好研究计划并确定文章结构。研究者可以选择Research Checklist(网址:http://www.equator-network.org/ )进行检查,该检查可以确认作者是否为编辑、同行评审专家和读者提供足够的信息,以了解研究是如何进行的,并判断研究结果是否可靠。

第三点需要注意的是,作者需要清晰地告诉同行评审及编辑“为什么这篇论文很有趣(Why is this paper interesting)”。因为作为编辑及评审在审阅文章时经常会问到“我们已经知道了什么?这篇文章会带给我们什么新的临床相关的信息?”作者必须说服编辑为什么这篇论文很重要,以及为什么人们想读它。

投稿“雷区”,这些点需注意

对于中国的投稿而言,最常见的问题是语言问题。

在阅读过程中虽然可以理解字里行间的意思,但是一旦被接受的话编辑部需要做大量的工作去修正。

同行评审及编辑选择文章时,首先会看Table和Figure,它们代表着整篇文章最核心的数据。而中国的投稿有时会提出一个复杂广泛的问题,但研究结果呈现于Table及Figure中却过于简单。

投稿Heart被立即拒稿的最常见的原因是,这篇研究没有提出一个符合Heart读者的好问题,或者提出的问题根本没有被回答;而有时候是因为文章内容与Heart需求不符,应该转投其他杂志。

需要注意的是,作者应该选择适合自己研究内容及方向的杂志进行投稿。

讨论有诀窍,主编来支招

一般来说,一篇文章中最难写的部分是讨论(Discussion),这部分应该怎么“套路”呢?

Catherine Otto告诉我们,首先针对此次研究结果进行简单小结,其次阐述此次工作与前人的研究有什么关联。接着,指出此次研究的局限性(limitations),最后,进行总结。

需要注意的是,不要过分夸大研究事实,也不要轻易提出在此初步研究的基础上能够实现医学实践的重大改变,应尽量讨论与该研究本身相关的问题。

Heart杂志对心血管疾病的临床研究,以及专题、综合评述和病例报告都会进行发表。

但是他们考虑发表的前提是,文章中提出的研究问题是不是全世界读者们想要了解的问题,而且是不是符合Heart杂志出版的类型。

如果一篇文章类型同时适合多种不同杂志发表,那么它在Heart被考虑发表的优先权就会降低。

别让影响因子影响你的研究!

中国的研究在近些年来飞速发展,不仅在研究数量上有所增加,其研究方向的发展也和国际同步。同时,中国心血管学者的研究在研究质量上也飞速提升。不过,许多研究者在投稿时总会关注影响因子的高低。

她认为,影响因子(impact factor)的高低不能代表研究本身的好坏。它相当于一种标志,高的影响因子代表有更多的人会看到并引用你的研究。

但是,你的研究能够发表到同行评审的期刊并让其他学者看到,应该是更重要的。同时,高影响因子的期刊对于研究者来说代表着更好的平台及质量,但是研究者们的研究不应该被高的影响因子所限制。

现在有很多方式可以分享研究者们的研究,包括Twitter,Facebook等。


图:Catherine Otto教授解答梅斯小编提问

2018年12月1-2日在上海举行的ACC亚洲会议上Otto教授提出,空气污染是心血管疾病的危险因素,这是全世界都在面临的问题,她在Heart杂志上也发表了相关研究。她指出,相关研究的发表可供政策决策者们参考,去做出一些改变。

总之,一个好的研究应该提出大家都感兴趣的、想要知道答案的问题,同时研究者不应该过度重视影响因子,而应该专注于研究本身。

在设计一项研究时,需要最先确定好研究计划及框架。

最后在投稿时,应该选择适合文章内容的杂志,而非一味地追求高分或影响力。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1703319, encodeId=ce0f1e0331914, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Jan 06 06:08:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848666, encodeId=df1718486668f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Apr 04 15:08:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356927, encodeId=103535692e84, content=主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:59 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356192, encodeId=2710356192fb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Dec 23 13:45:33 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357035, encodeId=5ad3135e03584, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563025, encodeId=14ec15630256b, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356105, encodeId=d77435610586, content=子刊主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:14:42 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1703319, encodeId=ce0f1e0331914, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Jan 06 06:08:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848666, encodeId=df1718486668f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Apr 04 15:08:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356927, encodeId=103535692e84, content=主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:59 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356192, encodeId=2710356192fb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Dec 23 13:45:33 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357035, encodeId=5ad3135e03584, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563025, encodeId=14ec15630256b, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356105, encodeId=d77435610586, content=子刊主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:14:42 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
    2019-04-04 gaoxiaoe
  3. [GetPortalCommentsPageByObjectIdResponse(id=1703319, encodeId=ce0f1e0331914, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Jan 06 06:08:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848666, encodeId=df1718486668f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Apr 04 15:08:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356927, encodeId=103535692e84, content=主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:59 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356192, encodeId=2710356192fb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Dec 23 13:45:33 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357035, encodeId=5ad3135e03584, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563025, encodeId=14ec15630256b, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356105, encodeId=d77435610586, content=子刊主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:14:42 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
    2019-01-01 jyzxjiangqin

    主编的角度看文章发表。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1703319, encodeId=ce0f1e0331914, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Jan 06 06:08:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848666, encodeId=df1718486668f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Apr 04 15:08:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356927, encodeId=103535692e84, content=主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:59 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356192, encodeId=2710356192fb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Dec 23 13:45:33 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357035, encodeId=5ad3135e03584, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563025, encodeId=14ec15630256b, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356105, encodeId=d77435610586, content=子刊主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:14:42 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
    2018-12-23 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1703319, encodeId=ce0f1e0331914, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Jan 06 06:08:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848666, encodeId=df1718486668f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Apr 04 15:08:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356927, encodeId=103535692e84, content=主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:59 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356192, encodeId=2710356192fb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Dec 23 13:45:33 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357035, encodeId=5ad3135e03584, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563025, encodeId=14ec15630256b, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356105, encodeId=d77435610586, content=子刊主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:14:42 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
    2018-12-23 zhaojie88
  6. [GetPortalCommentsPageByObjectIdResponse(id=1703319, encodeId=ce0f1e0331914, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Jan 06 06:08:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848666, encodeId=df1718486668f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Apr 04 15:08:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356927, encodeId=103535692e84, content=主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:59 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356192, encodeId=2710356192fb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Dec 23 13:45:33 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357035, encodeId=5ad3135e03584, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563025, encodeId=14ec15630256b, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356105, encodeId=d77435610586, content=子刊主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:14:42 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
    2018-12-23 slcumt
  7. [GetPortalCommentsPageByObjectIdResponse(id=1703319, encodeId=ce0f1e0331914, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Jan 06 06:08:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1848666, encodeId=df1718486668f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Apr 04 15:08:00 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356927, encodeId=103535692e84, content=主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Jan 01 19:32:59 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356192, encodeId=2710356192fb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Dec 23 13:45:33 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357035, encodeId=5ad3135e03584, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563025, encodeId=14ec15630256b, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sun Dec 23 08:08:00 CST 2018, time=2018-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356105, encodeId=d77435610586, content=子刊主编的角度看文章发表。, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Dec 22 18:14:42 CST 2018, time=2018-12-22, status=1, ipAttribution=)]
    2018-12-22 jyzxjiangqin

    子刊主编的角度看文章发表。

    0

相关资讯

写论文如导大片, 投论文如谈恋爱

1.“忌早恋”对于谈恋爱而言,早恋的危害,在知名作家肖复兴先生写的小说《早恋》已有深刻描述。未成年人过早谈恋爱可能会危害人的一生,同样的道理,一篇文章,其实很多情况下就相当于一个故事,故事还没有讲完,还不完整,还没有发育成熟,就由于种种原因(比如急着毕业、职称晋升等)仓促投出去,这样做的害处是很明显的,和早恋类似,有点自己作践自己。因为这样的稿件,投出去,往往都过不了编辑部内审这一关,现在象样

SCI投稿前必看:哪些期刊的自引率超过30%

SCI期刊的自引率,一直是我们投稿时最头痛的事情,如何辨别呢?其实,在我们投稿过程中,编辑部偶尔也会要求或是引导作者去引用1-2篇自己期刊的文章。

科研人员与投稿身份识别码(ORCID)是怎么回事?

什么是ORCID?ORCID(开放研究者与贡献者身份)识别码会保留特定的 ISNI 识别码给学术研究者,并由独立机构管理。ORCID Registry 于 2012 年 10 月推出,包含针对研究者和学术人员 的唯一标识符 (ORCID iD)。 此外,Registry 还能让您指定 您可与其交换信息的“可信组织”。 许多出版商和 授权机构已经开始要求随稿提供 ORCID iD,以便更好地将 研究

除了Oncotarget,还有哪些5-10分的期刊适合我们?

前段时间,我们整理了可发表中医/药、针灸、meta分析的SCI期刊,今天我们整理了中国人每年的发文量超过10篇的5-10分SCI期刊,供大家参考。

写一篇让编辑挑不出毛病的SCI论文,一定要注意这几点

一篇好的论文经常会在小细节方面就极其注意,SCI论文写作是个大工程,需要注意的细节太多,在实际的写作过程中也很容易被忽略。今天小编盘点了SCI论文写作的细节,方便大家作为checklist对论文进行检查,这些小细节虽然不至于对评审结果产生重大影响,却也可能决定了论文的发表命运。初稿之后,逐一检查以下各项:1. 一句话概况文章创新点(写下来),通读全文看是否突出了创新点。2.?标题:是否与内容一

如何在SCI投稿过程中写出加分信件(含cover letter,催稿信等)

一、最初投稿Cover letterDear Editors:We would like to submit the enclosed manuscript entitled “Paper Title”, which we wish to be considered for publication in “Journal Name”. No conflict of interest exits